https://www.live-feeds.com/feed/novartis-novo-nordisk-drug-failures-will-likely-pop-a-hole-in-the-balloon-of-the-fieldContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/novartis-novo-nordisk-drug-failures-will-likely-pop-a-hole-in-the-balloon-of-the-fieldhttps://www.live-feeds.com/feed/novartis-novo-nordisk-drug-failures-will-likely-pop-a-hole-in-the-balloon-of-the-field#u67158Sun, 13 Sep 2026 18:22:43 +0000Drug failures at Novartis and Novo Nordisk have created significant instability in the multibillion-dollar race for new cholesterol treatments. The failure of a Novartis heart drug specifically rattled the market for rival treatments, leading some analysts to suggest these setbacks will pop a hole in the balloon of the entire field. These results cast doubt on the viability of current development paths for high-promise heart medications, impacting investor confidence and the perceived trajectory of the sector.Why it mattersPharmaceutical companies have been competing in a high-stakes race to d